Research ExplorerPublications[Experiences with monoclonal antibody orthoclone OKT3 follow...

[Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]

Standard

[Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]. / Kraemer-Hansen, H; Henne-Bruns, D; Schröder, S; Löning, Thomas; Dittmer, R; Kremer, B.

In: Z GASTROENTEROL, Vol. 29, No. 9, 9, 1991, p. 422-425.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kraemer-Hansen, H, Henne-Bruns, D, Schröder, S, Löning, T, Dittmer, R & Kremer, B 1991, '[Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]', Z GASTROENTEROL, vol. 29, no. 9, 9, pp. 422-425. <http://www.ncbi.nlm.nih.gov/pubmed/1662431?dopt=Citation>

APA

Kraemer-Hansen, H., Henne-Bruns, D., Schröder, S., Löning, T., Dittmer, R., & Kremer, B. (1991). [Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]. Z GASTROENTEROL, 29(9), 422-425. [9]. http://www.ncbi.nlm.nih.gov/pubmed/1662431?dopt=Citation

Vancouver

Kraemer-Hansen H, Henne-Bruns D, Schröder S, Löning T, Dittmer R, Kremer B. [Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]. Z GASTROENTEROL. 1991;29(9):422-425. 9.

Bibtex

@article{03b6f2c24a084d45b4bf3111c4050adb,
title = "[Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]",
abstract = "In 7 patients 10 cycles (5 to 21 days, dosage: 30 to 430 mg, median 138 mg) of OKT3 therapy were performed after liver transplantation. In all patients reactivation of an EBV-infection with hepatitis was observed. Two patients treated with high dosages (430 mg respectively 195 mg) developed lymphoproliferative lesions. In one patient with persistent EBV-infection (dosage: 360 mg) a B-cell-lymphoma was diagnosed. This patient died 26 months after transplantation.",
author = "H Kraemer-Hansen and D Henne-Bruns and S Schr{\"o}der and Thomas L{\"o}ning and R Dittmer and B Kremer",
year = "1991",
language = "Deutsch",
volume = "29",
pages = "422--425",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "9",

}

RIS

TY - JOUR

T1 - [Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation]

AU - Kraemer-Hansen, H

AU - Henne-Bruns, D

AU - Schröder, S

AU - Löning, Thomas

AU - Dittmer, R

AU - Kremer, B

PY - 1991

Y1 - 1991

N2 - In 7 patients 10 cycles (5 to 21 days, dosage: 30 to 430 mg, median 138 mg) of OKT3 therapy were performed after liver transplantation. In all patients reactivation of an EBV-infection with hepatitis was observed. Two patients treated with high dosages (430 mg respectively 195 mg) developed lymphoproliferative lesions. In one patient with persistent EBV-infection (dosage: 360 mg) a B-cell-lymphoma was diagnosed. This patient died 26 months after transplantation.

AB - In 7 patients 10 cycles (5 to 21 days, dosage: 30 to 430 mg, median 138 mg) of OKT3 therapy were performed after liver transplantation. In all patients reactivation of an EBV-infection with hepatitis was observed. Two patients treated with high dosages (430 mg respectively 195 mg) developed lymphoproliferative lesions. In one patient with persistent EBV-infection (dosage: 360 mg) a B-cell-lymphoma was diagnosed. This patient died 26 months after transplantation.

M3 - SCORING: Zeitschriftenaufsatz

VL - 29

SP - 422

EP - 425

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 9

M1 - 9

ER -